The signs of an alcoholic are not always obvious, and many people who meet the clinical criteria for alcohol use disorder (AUD) continue working, maintaining relationships, and appearing functional on the outside. Alcohol use disorder is defined by the DSM-5-TR as a problematic pattern of alcohol use causing clinically significant impairment or distress, diagnosed when a person meets at least 2 of 11 specific criteria within a 12-month period. Recognizing the behavioral, physical, and psychological signs is the first step toward getting help.

Key Takeaways

• According to the 2024 National Survey on Drug Use and Health (NSDUH), 27.9 million people ages 12 and older, 9.7% of that age group, met criteria for alcohol use disorder in the past year, per the National Institute on Alcohol Abuse and Alcoholism (NIAAA).
• Alcohol use disorder is diagnosed across three severity levels: mild (2 to 3 DSM-5-TR criteria), moderate (4 to 5 criteria), and severe (6 or more criteria), meaning AUD exists on a spectrum, not as a single endpoint.
• Many people with AUD are high-functioning, meaning external performance at work or home does not rule out a clinically significant alcohol problem.
• FDA-approved medications for AUD, naltrexone, acamprosate, and disulfiram, are prescribed to only 1.6% of adults with past-year AUD, per a 2021 NIAAA analysis, despite strong evidence for their effectiveness.
• Physical signs including spider angiomas, jaundice, rosacea flares, and persistent facial puffiness can indicate hepatic and vascular damage from chronic alcohol use before internal organ disease is formally diagnosed.

What Alcohol Use Disorder Actually Means

The term “alcoholic” is widely used but is not a DSM-5-TR clinical designation. The correct clinical term is alcohol use disorder (AUD), which replaced the older DSM-IV categories of alcohol abuse and alcohol dependence in 2013. This change unified two previously separate diagnoses into one spectrum condition rated by severity.

The 11 DSM-5-TR Criteria for AUD

A clinician diagnoses AUD when a person meets at least 2 of the following 11 criteria within the same 12-month period. The number of criteria met determines severity:

• Impaired control over amount: Drinking more or for longer than intended, despite trying to limit intake.
• Persistent desire to cut down: Repeated unsuccessful efforts to reduce or stop drinking.
• Excessive time spent drinking: A large portion of daily or weekly time consumed by obtaining alcohol, drinking, or recovering from its effects.
• Craving: A strong urge or compulsion to drink that is difficult to suppress, added explicitly in DSM-5.
• Failure to fulfill role obligations: Recurrent alcohol use causing failure at work, school, or home responsibilities.
• Continued use despite social problems: Persistent drinking despite interpersonal conflict caused or worsened by alcohol.
• Giving up activities: Important social, occupational, or recreational activities are reduced or abandoned due to drinking.
• Use in physically hazardous situations: Driving, operating machinery, or other high-risk activities while impaired.
• Continued use despite physical or mental health consequences: Drinking persists even when the person knows it is worsening a health condition.
• Tolerance: Needing markedly more alcohol to achieve the same effect, or experiencing a reduced effect from the same amount.
• Withdrawal: Experiencing tremors, sweating, nausea, anxiety, or seizures when alcohol is reduced or stopped.

AUD Severity Levels

Severity determines appropriate level of care. Mild AUD (2 to 3 criteria) often responds to outpatient intervention and behavioral therapy. Moderate AUD (4 to 5 criteria) typically warrants structured programming such as a partial hospitalization program or intensive outpatient program. Severe AUD (6 or more criteria), particularly when physical dependence and withdrawal are present, may require medically supervised detoxification before outpatient treatment can begin.

Why Alcoholics Lie and Deny: The Neuroscience of Denial

Denial is not simply a moral or personality failing. Chronic heavy alcohol use produces structural and functional changes in the prefrontal cortex, the brain region responsible for self-monitoring, insight, and accurate self-assessment. Prefrontal cortical thinning impairs the very neural machinery required to recognize one’s own problematic behavior patterns.

Rationalization, Minimization, and Blaming

Research published in Drug and Alcohol Dependence found that a majority of individuals with AUD deny having a problem despite endorsing specific alcohol-related difficulties when asked directly. Three primary defense mechanisms drive this pattern:

• Rationalization: Constructing logical-sounding explanations for drinking, “I only drink because of work stress”, that attribute the behavior to external causes rather than internal compulsion.
• Minimization: Systematically underreporting quantity and frequency, “I only have a few drinks”, often genuine rather than deliberate, because impaired self-monitoring produces inaccurate self-reporting.
• Blaming: Directing responsibility for negative consequences outward, “My spouse makes me drink”, which interrupts the acknowledgment necessary for help-seeking behavior.

Why Lying Protects Continued Use

The mesolimbic dopamine pathway, which processes reward and motivation, assigns high salience to alcohol cues in people with AUD. This neurobiological prioritization produces behavior that resembles deliberate deception but often reflects genuine cognitive distortion. Understanding this mechanism is critical when approaching a loved one: confrontational pressure tends to increase defensiveness, while motivational interviewing techniques that build discrepancy between stated values and actual behavior produce better engagement with treatment programs.

Early Signs of Alcoholism to Watch For

Early-stage AUD is frequently missed because the external functioning of the person remains largely intact. The behavioral and psychological signals appear before physical dependence is established.

Behavioral Early Warning Signs

Early signs in behavior include:

• Drinking to manage emotions: Using alcohol consistently to relieve anxiety, stress, loneliness, or boredom rather than for social enjoyment, which reflects the development of negative reinforcement-driven use.
• Preoccupation with the next drink: Planning social events around drinking availability, feeling restless or irritable when alcohol is not accessible, or arriving at events specifically to drink.
• Increasing tolerance: Needing two or three drinks to feel what one drink used to produce, reflecting neuroadaptive changes in GABA receptor sensitivity and glutamate system upregulation.
• Drinking faster than others: Consuming alcohol at a noticeably quicker pace in social settings, often refilling before others have finished their first drink.
• Morning drinking or drinking to stop shaking: Using alcohol to suppress early withdrawal symptoms such as tremor, sweating, or anxiety, which signals physical dependence has begun.

Psychological Early Warning Signs

Psychological signs that precede physical dependence include:

• Blackouts or memory gaps: Alcohol-induced anterograde amnesia, in which the hippocampus fails to encode new memories during heavy drinking episodes, produces gaps in recollection that the person may rationalize or conceal.
• Defensiveness when drinking is mentioned: An outsized reaction to questions about alcohol use, including anger, deflection, or humor, often reflects the cognitive dissonance between actual use and self-concept.
• Guilt or remorse after drinking: Recognizing that last night’s drinking exceeded intentions but being unable to reliably moderate the next episode, one of the clearest internal signals of impaired control.
• Isolating to drink alone: Withdrawing from social drinking contexts to drink in private, which removes social monitoring and accelerates escalation of intake.

The Stages of Alcoholism: Jellinek’s Model and the AUD Spectrum

E. Morton Jellinek, a pioneering researcher in the study of alcohol dependence, described progressive phases of alcoholism in 1952, which led to the widely referenced Jellinek curve. The curve maps the deterioration arc from early social drinking through physical addiction and crisis, then bends upward into the rehabilitation phase, making explicit that recovery is the natural continuation of the progression, not an exception to it.

Stage 1: Early-Stage Alcoholism

Early-stage alcoholism is characterized by increasing tolerance, emotional drinking, and the beginning of preoccupation with alcohol. The AUDIT (Alcohol Use Disorders Identification Test), a 10-item screening tool developed by the World Health Organization, is designed to detect hazardous and harmful alcohol use at this stage. An AUDIT score of 8 to 14 indicates hazardous or harmful consumption; a score of 15 or higher indicates the likelihood of alcohol dependence. At this stage, most individuals do not see themselves as having a problem.

Stage 2: Middle-Stage Alcoholism

Middle-stage AUD is marked by loss of consistent control over drinking, the appearance of withdrawal symptoms between drinking episodes, and the erosion of non-alcohol-related activities. Physical dependence on alcohol is established in the middle stage: the brain’s GABA receptor system has downregulated in response to chronic alcohol exposure, and glutamate activity has upregulated to compensate, producing rebound hyperexcitability when alcohol is removed. This neuroadaptation drives the tremors, sweating, tachycardia, and anxiety of alcohol withdrawal syndrome.

Stage 3: Late-Stage and End-Stage Alcoholism

Late-stage alcoholism involves daily compulsive drinking driven by the need to avoid withdrawal rather than to experience pleasure, a shift from positive reinforcement to negative reinforcement as the primary motivator. End-stage alcoholism produces severe organ damage, including alcoholic cirrhosis, alcoholic cardiomyopathy, and Wernicke-Korsakoff syndrome, a thiamine (vitamin B1) deficiency-driven neurological condition producing anterograde and retrograde amnesia, confusion, and ataxia. Alcohol withdrawal seizures and delirium tremens represent life-threatening medical emergencies in late-stage AUD.

Physical Signs of an Alcoholic: What Chronic Drinking Does to the Body

Chronic heavy alcohol use produces systemic organ damage that manifests externally before formal diagnosis in many cases. Physical signs visible to observers often indicate hepatic, vascular, and cutaneous damage already underway.

Common Physical Signs

Early and moderate physical signs of AUD include:

• Persistent facial redness: Ethanol is a potent vasodilator that expands superficial blood vessels in the face. Repeated vasodilation damages capillary walls over time, producing chronic redness across the cheeks and nose that persists even without active drinking.
• Facial puffiness and morning swelling: Alcohol disrupts antidiuretic hormone (ADH) function, producing dehydration followed by compensatory fluid retention. The face, particularly around the eyes, swells noticeably in the morning after heavy use.
• Rosacea flares: Chronic alcohol use triggers inflammatory mediators that exacerbate rosacea in genetically susceptible individuals. A 2017 study of 82,737 women found heavy alcohol intake of 30 grams or more per day increased rosacea risk by 53%.
• Bloodshot or glassy eyes: Conjunctival injection from vasodilation and impaired sleep architecture both contribute to chronically reddened, unfocused eyes distinct from acute intoxication.
• Broken capillaries and spider veins: Visible dilated vessels on the cheeks and nose reflect chronic vasodilation weakening vessel walls. These telangiectasias may persist even after abstinence.

Severe Physical Signs

Advanced physical signs indicate significant organ involvement:

• Spider angiomas: Small central blood vessels with radiating branches visible on the face, chest, and upper arms. Elevated circulating estrogen from impaired hepatic metabolism causes spider angiomas in alcoholic liver disease; their presence clusters with portal hypertension and cirrhosis.
• Jaundice: Yellowing of the skin and sclerae occurs when the damaged liver cannot adequately process bilirubin, a byproduct of red blood cell breakdown. Jaundice indicates serious hepatic dysfunction requiring immediate medical evaluation.
• Palmar erythema: Persistent redness of the palms caused by elevated estrogen levels from liver dysfunction and altered peripheral circulation, commonly seen in alcoholic liver disease.
• Tremors at rest: Resting tremors that appear in the morning or between drinks reflect the neurological hyperexcitability of alcohol withdrawal syndrome and indicate established physical dependence.
• Rhinophyma: A bulbous, thickened deformation of the nasal skin caused by sebaceous gland hypertrophy. Though historically associated with heavy drinking, rhinophyma is primarily driven by chronic rosacea; alcohol aggravates but does not cause it directly.

Long-Term Physical Consequences

Long-term systemic effects of severe AUD include:

• Alcoholic liver disease progression: Moving from alcoholic fatty liver through alcoholic hepatitis to cirrhosis, each stage producing progressively irreversible hepatocellular damage and portal hypertension.
• Alcoholic cardiomyopathy: Ethanol and its metabolite acetaldehyde directly damage cardiomyocytes, producing a dilated, weakened heart muscle that reduces ejection fraction and increases risk of arrhythmia and heart failure.
• Wernicke-Korsakoff syndrome: Thiamine deficiency from poor nutrition and impaired intestinal absorption produces Wernicke’s encephalopathy acutely (confusion, ataxia, ophthalmoplegia) and Korsakoff’s psychosis chronically (anterograde amnesia, confabulation).
• Peripheral neuropathy: Alcohol-related nutritional deficiencies and direct neurotoxicity produce numbness, burning pain, and weakness, particularly in the lower extremities.
• Premature skin aging: Ethanol accelerates collagen degradation through oxidative stress, producing deeper wrinkles, skin laxity, and an aged appearance earlier than expected by chronological age.

Signs of a High-Functioning Alcoholic

High-functioning alcoholic is not a DSM-5-TR diagnostic term but describes individuals who meet criteria for AUD while maintaining the appearance of a normal or successful life. The clinical mechanism is not immunity to damage but rather that professional performance and social presentation often remain intact during earlier AUD stages while physiological and psychological deterioration progresses internally.

Why High-Functioning AUD Is Harder to Identify

Signs specific to high-functioning AUD include:

• Drinking heavily but “holding it together”: Appearing largely functional at work or in social settings despite consuming quantities that exceed NIAAA low-risk drinking guidelines, more than 4 drinks on any single day or more than 14 drinks per week for men, more than 3 drinks on any single day or more than 7 per week for women.
• Using professional success as evidence of no problem: Invoking career achievement as proof that drinking is not an issue, which sidesteps the DSM-5-TR criterion that impaired control alone, not external consequences, constitutes a diagnostic signal.
• Rigid drinking rituals: Structuring the day around drinking times (the “5 o’clock drink” that cannot be skipped) or becoming visibly anxious when circumstances prevent drinking at the usual hour.
• Functioning worse without alcohol: Experiencing pronounced anxiety, irritability, or concentration difficulty on days without alcohol, reflecting neuroadaptation that requires alcohol to restore baseline functioning.

Signs of Alcoholism in Others: What Families Notice First

Family members and close contacts frequently observe behavioral changes before the person with AUD acknowledges any problem. Because impaired self-monitoring is a neurological feature of chronic heavy drinking rather than willful blindness, external observers often have more accurate information about the pattern of use than the drinker themselves.

Behavioral Changes in Relationships

Observable signs in someone else’s behavior include:

• Shifting personality when drinking: Becoming notably more aggressive, tearful, or impulsive after drinking than baseline personality would predict, reflecting alcohol’s disinhibitory effect on the prefrontal cortex.
• Hiding alcohol or lying about consumption: Concealing bottles, misrepresenting how much was consumed, or becoming defensive or evasive when asked direct questions about drinking.
• Prioritizing drinking over family commitments: Arriving late to or leaving early from family events, missing children’s activities, or choosing social contexts centered on alcohol over family obligations consistently.
• Financial problems connected to drinking: Money disappearing without explanation, missing bill payments, or secretive spending on alcohol that exceeds a household’s budget.
• Declining interest in previous hobbies: Abandoning activities that were once central to identity, sport, creative pursuits, community involvement, as alcohol increasingly fills free time and recovery time expands.

Alcohol Use Disorder vs. Heavy Drinking: How to Tell the Difference

Heavy drinking and AUD exist on the same continuum but are not identical. Heavy drinking, as defined by NIAAA, describes a pattern that exceeds low-risk limits but does not necessarily produce the impaired control and clinically significant distress required for an AUD diagnosis.

Treatment for Alcohol Use Disorder

Alcohol use disorder is a treatable medical condition. Multiple evidence-based interventions reduce drinking, prevent relapse, and restore function. The NIAAA recommends offering both pharmacological and behavioral treatment options simultaneously for moderate to severe AUD.

First-Line Behavioral Therapies

Evidence-based behavioral treatments for AUD include:

• Cognitive Behavioral Therapy (CBT): CBT for AUD targets the automatic thoughts and environmental triggers that drive alcohol use, building functional analysis skills and coping strategies that replace drinking as a response to stress, craving, and negative emotion.
• Motivational Interviewing (MI): MI resolves ambivalence about change by helping the person articulate their own reasons for reducing drinking. MI is particularly effective for individuals in denial or early contemplation stages because it avoids confrontation and strengthens intrinsic motivation.
• Dialectical Behavior Therapy (DBT): DBT addresses the emotion dysregulation that frequently underlies alcohol use in individuals with co-occurring mood disorders, personality disorders, or trauma histories.
• 12-Step Facilitation and SMART Recovery: Structured peer support programs that provide community accountability and relapse prevention frameworks. SMART Recovery applies CBT and motivational principles in a secular mutual aid format.

FDA-Approved Pharmacological Treatments

Three medications are FDA-approved for AUD, yet remain dramatically undertreated, prescribed to only 1.6% of adults with past-year AUD per NIAAA:

• Naltrexone (oral or extended-release injectable Vivitrol): A mu-opioid receptor antagonist that blocks the euphoric and rewarding effects of alcohol by preventing dopamine release in the mesolimbic pathway. Reduces heavy drinking days and craving, available in daily oral form or as a monthly injectable.
• Acamprosate (Campral): Acts as a glutamate NMDA receptor modulator and GABA agonist to reduce the neurological hyperexcitability that drives craving and discomfort during sustained abstinence. Promotes and maintains abstinence; requires normal kidney function.
• Disulfiram (Antabuse): Inhibits aldehyde dehydrogenase, causing acetaldehyde to accumulate when alcohol is consumed, producing nausea, flushing, and severe discomfort. Effective as a deterrent for motivated patients who want a pharmacological barrier to relapse.

Second-Line and Emerging Treatments

Second-line pharmacological options include topiramate and gabapentin, which the American Psychiatric Association recommends for patients who have not responded to FDA-approved medications or who prefer these agents. Emerging evidence supports ketamine-assisted therapy for AUD, with several Phase 2 clinical trials demonstrating reductions in craving and drinking frequency, currently an off-label investigational approach. Transcranial magnetic stimulation (TMS) targeting the dorsolateral prefrontal cortex is in Phase 2 to Phase 3 trials for reducing alcohol craving by modulating prefrontal-mesolimbic connectivity.

Treatment at Ascend Recovery Center

Ascend Recovery Center in Palm Beach Gardens, Florida, provides Joint Commission-accredited outpatient treatment for alcohol use disorder across multiple levels of care. Clients who require medically supervised detox are referred to partner facilities and step directly into Ascend’s structured programming upon stabilization.

PHP: Structured Daily Treatment

Ascend’s Partial Hospitalization Program runs Monday through Friday from 9:00 AM to 3:15 PM, delivering six-plus hours of daily clinical programming. Groups begin at 9:00 AM and run through 3:15 PM, covering CBT, DBT, Narrative Therapy, 12-step facilitation, and relapse prevention. Individual therapy is provided weekly. Trauma-informed group work is led by a trauma-certified counselor on staff, addressing the co-occurring trauma histories that frequently underlie AUD. Medication-assisted treatment, including naltrexone and acamprosate maintenance, is available and coordinated through Ascend’s medical director.

IOP: Intensive Outpatient Structure

Ascend’s Intensive Outpatient Program provides structured daytime clinical hours for patients stepping down from PHP or entering at a lower level of care. IOP includes biweekly individual therapy sessions with weekly check-in meetings, group programming across the same clinical modalities as PHP, and case management covering FMLA coordination, legal support with proper releases, and community resource connection.

Brain Mapping, Art Therapy, and Holistic Programming

Ascend incorporates brain mapping, a quantitative EEG-based neuroscience assessment, to identify each patient’s individual neurological patterns and personalize treatment accordingly. This adds a precision medicine dimension to AUD care that generic group programming cannot replicate. Art therapy provides a structured nonverbal processing channel for patients whose trauma or emotional histories are difficult to access through talk therapy alone. Supplemental holistic programming includes yoga, mindfulness groups, and SMART Recovery alongside traditional 12-step facilitation.

FARR-Certified Housing and Transportation

Ascend owns its FARR-certified recovery residences in Florida, providing structured sober living that operates as a direct extension of clinical programming rather than a separate housing arrangement. Staff transport residents to and from treatment, outside meetings, court dates, and medical appointments, removing the logistical barriers that cause treatment dropout. Weekend programming coordinated through community housing includes hiking, kayaking, and outdoor activities, with Florida’s climate supporting year-round participation.

Frequently Asked Questions

What is the difference between an alcoholic and a heavy drinker?

A heavy drinker exceeds NIAAA quantity thresholds but can typically limit or stop when motivated. An alcoholic, or someone with AUD, meets at least 2 DSM-5-TR diagnostic criteria, including impaired control over intake despite genuine efforts to stop. The key distinction is loss of consistent control, not just volume of consumption.

Can someone be an alcoholic without getting drunk?

Yes. Individuals with established tolerance may consume large quantities of alcohol without appearing visibly intoxicated because neuroadaptation has raised their effective blood alcohol concentration threshold. Absence of visible intoxication does not rule out AUD and is itself a sign of significant tolerance development.

Do alcoholics always get hangovers?

Not necessarily. As tolerance increases with chronic heavy use, hangover symptoms may decrease or become indistinguishable from early withdrawal symptoms, tremor, anxiety, sweating, that appear in the morning and resolve with the first drink. When morning drinking eliminates “hangover” symptoms, it signals physical dependence rather than benign tolerance.

What are the facial signs of an alcoholic?

Visible facial signs of chronic heavy alcohol use include persistent redness from capillary vasodilation, spider angiomas indicating liver dysfunction, morning facial puffiness from fluid retention, rosacea flares, and premature wrinkling from accelerated collagen breakdown. Jaundice, yellowing of the skin and whites of the eyes, indicates serious liver disease requiring immediate medical attention.

Why do alcoholics in denial get angry when confronted?

Denial in AUD is partly neurological: prefrontal cortical thinning impairs accurate self-assessment, while mesolimbic dopamine system changes assign high threat value to anything that risks access to alcohol. Confrontation triggers this defensive response reflexively. Motivational interviewing, which avoids direct confrontation and instead builds the person’s own awareness of the gap between their values and their behavior, produces substantially better outcomes than direct challenge.

What is the CAGE-AID and how is it used?

The CAGE-AID (Cut down, Annoyed, Guilty, Eye-opener, Adapted to Include Drugs) is a 4-question clinical screening tool. Two or more positive responses indicate a need for full clinical evaluation for AUD. It is commonly used in primary care and during intake assessments at treatment programs to identify individuals who need a formal diagnostic evaluation.

Can AUD be treated without residential rehab?

Yes. Moderate AUD frequently responds well to structured outpatient treatment, including partial hospitalization programs and intensive outpatient programs, combined with medication-assisted treatment. Residential placement is typically indicated for severe AUD with concurrent homelessness, lack of social support, or significant psychiatric instability, not as a default for all presentations.

At what point does drinking become alcoholism?

Drinking becomes AUD when a person meets at least 2 of the 11 DSM-5-TR criteria within 12 months. The clearest early signal is repeated failed attempts to control intake, drinking more or longer than intended despite genuine intentions to stop. A clinician using the AUDIT screening tool or a full DSM-5-TR evaluation can determine whether diagnostic criteria are met.

References

1. American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.). American Psychiatric Publishing. https://doi.org/10.1176/appi.books.9780890425787
2. National Institute on Alcohol Abuse and Alcoholism. (2025). Alcohol use disorder (AUD) in the United States: Age groups and demographic characteristics. NIAAA. https://www.niaaa.nih.gov/alcohols-effects-health/alcohol-topics/alcohol-facts-and-statistics/alcohol-use-disorder-aud-united-states-age-groups-and-demographic-characteristics
3. National Institute on Alcohol Abuse and Alcoholism. (2024). Recommend evidence-based treatment: Know the options. NIAAA Core Resource on Alcohol. https://www.niaaa.nih.gov/health-professionals-communities/core-resource-on-alcohol/recommend-evidence-based-treatment-know-options
4. Schuckit, M. A., Smith, T. L., Danko, G. P., Trim, R., Bucholz, K., Edenberg, H., & Hesselbrock, V. (2020). Characteristics associated with denial of problem drinking among two generations of individuals with alcohol use disorders. Drug and Alcohol Dependence, 214, 108126.
5. Abram, K., Silm, H., Maaroos, H. I., & Oona, M. (2010). Risk factors associated with rosacea. Journal of the European Academy of Dermatology and Venereology, 24(5), 565–571.
6. Li, C. P., Lee, F. Y., & Hwang, S. J. (1999). Spider angiomas in patients with liver cirrhosis: Role of alcoholism and impaired liver function. Scandinavian Journal of Gastroenterology, 34(5), 520–523.
7. Jellinek, E. M. (1952). Phases of alcohol addiction. Quarterly Journal of Studies on Alcohol, 13(4), 673–684.
8. Substance Abuse and Mental Health Services Administration. (2024). Key substance use and mental health indicators in the United States: Results from the 2024 National Survey on Drug Use and Health. U.S. Department of Health and Human Services.